(Adds immunization background in the UK)
May 4 (Reuters) – Anyone over the age of 50 in Britain will receive a third vaccination against COVID-19 in the fall to try to eradicate all infection threats by Christmas newspaper. The Times reports
The newspaper said the two-choice trials were supervised by British chief medical officer Chris Whitty.
The first involves vaccines specifically adapted to tackle new strains, the second is the third of one of three versions already in use: Pfizer-BioNTech, Oxford-AstraZeneca or Moderna, the newspaper reported.
All of the more than 34.6 million people in the UK received the COVID-19 vaccine for the first time, government statistics show Tuesday.
The UK, with a population of 67 million, has agreements for more than 510 million different doses of the COVID-19 vaccine, some of which are still under development.
Britain will buy an additional 60 million doses of Pfizer / BioNTech’s vaccine, Health Minister Matt Hancock said last week in a deal that more than doubled the country’s supply ahead of a support program later this year.
The UK has now purchased a total of 100 million doses of Pfizer vaccine, one of three vaccinations in the country with COVID-19.
(Reporting by Kanishka Singh in Bengaluru; (Compiled by Leslie Adler and David Gregorio)